PAPER Barros-Viegas AT, Carmona V, Ferreiro E, Guedes J, Cardoso AM, Cunha P, Pereira de Almeida L, Resende de Oliveira C, Pedro de Magalhães J, Peça J, Cardoso AL
SEARCH RESULTS
4168 RESULTS
PAPER Howard R, Liu KY
Questions EMERGE as Biogen claims aducanumab turnaround.
Nat Rev Neurol. 2020 Feb;16(2):63-64. PubMed: 31784690PAPER Sokolov AA, Collignon A, Bieler-Aeschlimann M
Serious video games and virtual reality for prevention and neurorehabilitation of cognitive decline because of aging and neurodegeneration.
Curr Opin Neurol. 2020 Apr;33(2):239-248. PubMed: 32073439PAPER Hofer C, Kwitt R, Höller Y, Trinka E, Uhl A
An empirical assessment of appearance descriptors applied to MRI for automated diagnosis of TLE and MCI.
Comput Biol Med. 2020 Feb;117:103592. Epub 2019 Dec 23 PubMed: 32072961PAPER Valveny N, Esteban E, Kandil M, Moral P
APO E polymorphism in Spanish and Moroccan populations.
Clin Genet. 1997 May;51(5):354-6. PubMed: 9212187PAPER Hegele RA
Uncovering rare mutations: an unforeseen complication of routine genotyping of APOE.
Clin Chem. 1999 Sep;45(9):1579-81. PubMed: 10471671PAPER Dallongeville J
Apolipoprotein E mutations, type V hyperlipoproteinaemia and diet.
Br J Nutr. 2000 Jun;83(6):573-4. PubMed: 10911764PAPER Koopal C, Marais AD, Westerink J, Visseren FL
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.
J Clin Lipidol. 2017 Jan - Feb;11(1):12-23.e1. Epub 2016 Oct 13 PubMed: 28391878PAPER Vialettes B, Reynier P, Atlan-Gepner C, Mekki N, Lesluyes-Mazzochi L, Luc G, Lairon D, Malthiery Y
Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136--> Ser)
Br J Nutr. 2000 Jun;83(6):615-22. PubMed: 10911769PAPER Feussner G, Feussner V, Hoffmann MM, Lohrmann J, Wieland H, März W
Molecular basis of type III hyperlipoproteinemia in Germany.
Hum Mutat. 1998;11(6):417-23. PubMed: 9603433PAPER Hubácek JA, Adámková V, Skodová Z
Rare variant of apolipoprotein E (Arg136--> Ser) in two normolipidemic individuals.
Physiol Res. 2005;54(5):573-5. Epub 2005 Jan 10 PubMed: 15641930PAPER Pocovi M, Cenarro A, Civeira F, Myers RH, Casao E, Esteban M, Ordovas JM
Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136--> Ser) variant in multigenerational pedigree studies.
Atherosclerosis. 1996 Apr 26;122(1):33-46. PubMed: 8724110PAPER Civeira F, Pocoví M, Cenarro A, Casao E, Vilella E, Joven J, González J, Garcia-Otín AL, Ordovás JM
Apo E variants in patients with type III hyperlipoproteinemia.
Atherosclerosis. 1996 Dec 20;127(2):273-82. PubMed: 9125318PAPER Rolleri M, Vivona N, Emmanuele G, Cefalù AB, Pisciotta L, Guido V, Noto D, Fiore B, Barbagallo CM, Notarbartolo A, Travali S, Bertolini S, Averna MR
Two Italian kindreds carrying the Arg136--> Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele.
Nutr Metab Cardiovasc Dis. 2003 Apr;13(2):93-9. PubMed: 12929622PAPER Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel JM
Genotyping and sequence analysis of apolipoprotein E isoforms.
Genomics. 1988 Nov;3(4):373-9. PubMed: 3243553Current Filters
- Date Range : Nov 2019 to Feb 2020 x